Subjects | 27 | 10 | |
Male/female | 17/10 | 5/5 | 0.71 |
Age years | 30.9±17.2 | 28.4±9.5 | 0.67 |
Genotype | | | 0.50 |
F508del homozygous | 10 (37) | 6 (60) | |
F508del heterozygous | 15 (55.6) | 4 (40) | |
Other | 2 (7.4) | 0 | |
Pancreatic insufficiency | 21 (77.8) | 9 (90) | 0.65 |
CF-related diabetes | 6 (22.2) | 3 (30) | 0.68 |
FEV1 % predicted | 66.9±24.1 | 61.5±18.2 | 0.57 |
Pseudomonas aeruginosa# | 22 (81.5) | 8 (80) | 0.92 |
Duration of infection weeks¶ | 3.7±6.6 | 2.6±3.1 | 0.60 |
MRSA carrier nasal/skin swabs | 4 (14.8) | 6 (60) | 0.03 |